Techniques: Combining genetic and small molecule screens to identify therapeutic targets for rare cancers

Assays and screens

TECHNOLOGY: Cellular assays

A protocol that combines the results of gene editing, RNAi and small molecule screens in patient-derived cancer cell lines could help identify therapeutic targets for rare cancers lacking known

Read the full 331 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE